A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2017
Price : $35 *
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 26 Jul 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2016.
- 26 Jul 2016 Status changed from recruiting to active, no longer recruiting.